VMP 42275911000001105

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Olanzapine 20mg tablets
BNF code 040201060AAAQAQ
Virtual Therapeutic Moiety Olanzapine
Date identifier became valid 22 Sep 2023
Previous product identifier 374054003
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Olanzapine
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 20.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Olanzapine 20mg tablets (A A H Pharmaceuticals Ltd)
Olanzapine 20mg tablets (Accord-UK Ltd)
Olanzapine 20mg tablets (Alliance Healthcare (Distribution) Ltd)
Olanzapine 20mg tablets (Bristol Laboratories Ltd)
Olanzapine 20mg tablets (Crescent Pharma Ltd)
Olanzapine 20mg tablets (CST Pharma Ltd)
Olanzapine 20mg tablets (Dr Reddy's Laboratories (UK) Ltd)
Olanzapine 20mg tablets (Krka UK Ltd)
Olanzapine 20mg tablets (Medihealth (Northern) Ltd)
Olanzapine 20mg tablets (Milpharm Ltd)
Olanzapine 20mg tablets (Sigma Pharmaceuticals Plc)
Olanzapine 20mg tablets (Sun Pharma UK Ltd)
Olanzapine 20mg tablets (Teva UK Ltd)
Zyprexa 20mg tablets (Abacus Medicine Ltd)
Zyprexa 20mg tablets (CST Pharma Ltd)
Zyprexa 20mg tablets (Neon Healthcare Ltd)
Virtual Medicinal Product Packs
Olanzapine 20mg tablets 28 tablet

dm+d data retrieved from TRUD: release NHSBSA_11.3.0_20241125000001, imported on 26th November 2024 at 03:54:16.

Feedback